Core One Labs Inc C.COOL

Alternate Symbol(s): CLABF

Healthcare Cannabis Psychedelics

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.

CSE:COOL - Post by User

Core One Labs Inc

Bullboard Posts

Comment by Leafs4Lifeon Mar 20, 2018 6:10pm

133 Views

Post# 27749700

RE:Shorts are Clearly Back in Control

Short interest as of March 16th: 1.6 million shares sold short for a value of $1.23 million. Average price of 77 cents.

If we get news this week (as I expect we will) and shte share price reacts, we could get a mini squeeze.

Only headwind (other than investor apathy from lack of news) could be the Rorbacher ammendment being left out of the budget on the 23rd. That would be bad for all American cannabis companies. Fingers crossed they keep it in the budget.

sjsearcher wrote: Some good all of that recent company hype aboutt the new Reveur product line launch did. Stock is tanking again and shorts are back in control. This says a lot about the level of buying interest.

Bullboard Posts

NervGen Pharma: Proof that NVG-291 works?